Cardinal Health is a leading healthcare services and products company based in Dublin, Ohio, United States. The company provides a wide range of services including pharmaceutical distribution, medical products manufacturing, and healthcare solutions to hospitals, pharmacies, and other healthcare facilities. It was founded in 1971 as a small food distributor and subsequently expanded its operations into the healthcare industry.

Cardinal Health's headquarters is located in Dublin, Ohio. The state-of-the-art facility serves as the central hub for the company's strategic leadership, corporate functions, and administrative operations. In addition to its headquarters, Cardinal Health has a global presence with operations in more than 60 countries.

The company offers a diverse range of products and services. Its core offerings include pharmaceutical distribution and medical products manufacturing. Cardinal Health serves as a crucial link in the healthcare supply chain, distributing branded and generic pharmaceuticals, over-the-counter medications, and medical supplies to pharmacies, hospitals, and other healthcare providers across the United States and internationally.

Additionally, the company manufactures and sources a variety of medical and surgical products, such as surgical gowns, gloves, and surgical drapes. Cardinal Health operates several noteworthy subsidiaries, including Cordis, a cardiovascular and endovascular device company, and Cardinal Health China, which focuses on providing healthcare solutions in China. The company has also formed strategic partnerships and joint ventures with global entities such as Henry Schein, Inc.

In terms of market position, Cardinal Health is a dominant player in the global healthcare services industry. With over $152 billion in annual revenue, the company consistently ranks among the Fortune 500. Despite facing competition from other major players in the sector such as McKesson, AmerisourceBergen, and Owens & Minor, Cardinal Health has maintained a strong market position through its innovative products, efficient supply chain management, and a commitment to enhancing healthcare delivery.

In recent years, Cardinal Health has focused on organic and inorganic growth strategies. The company has expanded its product portfolio through acquisitions, divestitures, and partnerships. Notably, in 2017, it acquired certain patient recovery assets from Medtronic, further enhancing its medical products offering.

As of the latest available information, Cardinal Health continues to actively serve the global healthcare industry, providing essential services and products that contribute to patient care and improved healthcare outcomes